Clinical Trial: A systematic review of the functionality of "ampelopsin" for a function to reduce abdominal fat (visceral and subcutaneous fat), body weight, BMI, and blood lipids in healthy adults (Japan)

Tokyo, Aug. 9 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062502) titled 'A systematic review of the functionality of "ampelopsin" for a function to reduce abdominal fat (visceral and subcutaneous fat), body weight, BMI, and blood lipids in healthy adults' on Aug. 7.

Study Type: Others,meta-analysis etc

Primary Sponsor: Institute - Oryza Oil and Fat Chemical Co., Ltd.

Condition: Condition - The subjects were healthy adults (excluding those under 18 years old, pregnant women, and lactating women) Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The objective of this study is to investigate whether the intake of ampelopsin effect function t...